ClinicalTrials.gg
RecruitingNCT07045259Updated Nov 12, 2026

Effect of Exergaming Program Versus Neuromuscular Exercise in Elderly People With Motor Cognitive Risk Syndrome

An interventional study of The Neuromuscular Exercise Training program and Exergaming Exercise Training in Motoric Cognitive Risk Syndrome, Elderly (People Aged 65 or More) and Geriatric Patient, sponsored by Istanbul University - Cerrahpasa. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 10 months later.
Updated Nov 12, 2026Primary outcomes revisedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The primary aim of our study is to compare the effects of neuromuscular exercise training versus structured exergaming program on locomotor and cognitive functions in elderly individuals with Motor Cognitive Risk (MCR), which defines the transition state between typical aging and dementia and mild cognitive impairment. This study aims to present for the first time the effects of neuromuscular exercise training and exergaming program on locomotor and cognitive functions in elderly individuals with MCR with comparative results.

02

Conditions studied

  • Motoric Cognitive Risk Syndrome
  • Elderly (People Aged 65 or More)
  • Geriatric Patient
  • Exergaming
  • Neuromuscular Exercise

Keywords

  • Motoric Cognitive Risk Syndrome
  • Elderly
  • neuromuscular exercise
  • exergaming
03

In context

Lead sponsor

Istanbul University - Cerrahpasa is the lead sponsor of 702 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being over 65 years of age
  • Having a Barthel Daily Living Activities Index score of ≥ 90
  • Having a Mini Mental Status Score () of ≥24
  • Having the ability to walk with or without a walking aid
  • Having a slow walking speed
  • Having subjective memory complaints

Exclusion criteria

Exclusion Criteria:

  • Presence of Dementia
  • Major Depression
  • Generalized Anxiety Disorder and Delirium
  • Parkinson's Disease
  • Anemia
  • Thyroid Disease
  • Vitamin B12 Deficiency
  • Malnutrition
  • Terminal Illness
  • Hearing or Visual Impairment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    The Neuromuscular Exercise Group

    Other: Exergaming Exercise Training

  • Active comparator
    Exergaming Group

    Other: The Neuromuscular Exercise Training program

  • No intervention
    Control Group

Interventions

  • OtherThe Neuromuscular Exercise Training program

    The Neuromuscular Exercise Training program will be carried out in groups of 2 people for 60 minutes/2 days/8 weeks. The exercise program will consist of warm-up, loading and cooling phases. The warm-up phase will consist of flexibility exercises, mini squat and roll down etc. exercises to prepare the individual for exercise. The loading phase will consist of a cognitive-based neuromuscular exercise program aiming to provide stabilization, increase in balance, neuroplasticity and motor control and is planned to include strengthening exercises, stabilization exercises, balance-proprioceptive exercises and neuromuscular control exercise training with visual feedback. The exercises will progress gradually from easy to difficult with increasing repetition and set numbers.

  • OtherExergaming Exercise Training

    In our study, Xbox One Kinect game console and Kinect sensor will be used within the scope of Exergaming. Exergaming program will be carried out in groups of 2 people for 60 minutes/ 2 days/ 8 weeks. It will consist of warm-up, loading and cooling phases. The games to be used for the Exergaming program were selected from games that include locomotor and cognitive repetitive tasks. The selected exergames involve repetitive locomotor and cognitive tasks. Piano step will be utilized during the warm-up for its rhythm-based movement patterns. For the conditioning phase, lower extremity exercises will include Reflex Ridge, River Rush, and Rallyball (Kinect Adventures), while upper extremity exercises will consist of Bowling, Table Tennis, Swimming (Kinect Sports), and Fruit Ninja. A progressive training approach will be followed, with game difficulty levels increasing incrementally as the sessions advance.

06

What researchers measure

Primary outcomes

  1. Timed Up and Go Test (TUG)

    TUG test is a frequently used field test to evaluate mobility, balance, fall risk and walking in elderly individuals (Magda,2024; (Racha, 2023). The test involves the individual getting up from a chair, walking 3 meters, turning, and sitting. The time taken to complete this series of movements is measured and recorded using a stopwatch (Racha, 2023).

    Time frame: From enrollment to the end of treatment at 8 weeks

  2. Stair Climbing Test (SCT)

    The stair climbing test is frequently used in the evaluation of locomotor functions in elderly individuals. The validity and reliability of the STAIR, which has been investigated in elderly people with knee osteoarthritis, has been reported to have a test-retest reliability coefficient of 0.93 and high reliability (Jose, 2021). In our study, they will be asked to ascend and descend 9 steps, each of which is 50 cm wide, 15 cm high and 25 cm deep, as quickly but safely as possible. They will be able to use the handrails when they need to while ascending or descending the stairs, and the total time taken to complete the task will be measured in seconds with a stopwatch.

    Time frame: From enrollment to the end of treatment at 8 weeks

  3. Cognitive Officer TUG-SCT

    In our research * Counting backwards from 100 by threes * Cognitive officer TUG and SCT tests will be conducted to answer the questions prepared by the researchers as yes if red and no if blue, and the results will be recorded in terms of time (Li, 2023).

    Time frame: From enrollment to the end of treatment at 8 weeks

Secondary outcomes

  1. Short Physical Performance Battery (SPPB)

    Short Physical Performance Battery (SPPB) is a field test designed to evaluate the physical performance of elderly people, helps interpret their functional abilities, and gives an idea about the individual's biological age (Pavasini, 2016). SPPB, which is frequently used in elderly individuals in the literature, consists of the categories of static balance, 4-meter walking test, and 5-times sit-to-stand test (Corsonello, 2012 ). The balance test in SPPB includes three different postures: side-by-side, semi-tandem, and tandem. Each posture is held for up to 10 seconds. The ability to maintain these positions gives an idea about the individual's balance abilities (Cisternas, 2024). It is emphasized in the literature that the balance test, together with other components of SPPB, can predict all-cause mortality (Pahor, 2014). In our research, SPPB will be used to evaluate the static balance ability, walking speed, functional capacity,

    Time frame: From enrollment to the end of treatment at 8 weeks

  2. Dynamic Gait Index (DGI)

    The Dynamic Gait Index (DGI) is a widely accepted functional gait tool for assessing the risk of falls and functional stability while walking in the elderly (Shumway-Cook et al., 2013). In the literature, DGI is used as a valid, reliable, cheap and fast tool to assess the gait and balance of elderly individuals (Alghwiri, 2014). It consists of eight items including normal walking on level ground, walking with speed changes, walking with horizontal head movements, walking with vertical head movements, walking with pivot turns, walking by jumping over obstacles, taking steps around obstacles and climbing up and down stairs. Each item is rated on a 4-point scale ranging from 0 (severe impairment) to 3 (independent walking). The maximum total score can be 24. The scale, whose validity and reliability in Turkish in elderly individuals was conducted by Zirek, will be used to comprehensively assess walking in our study (Zirek, 2023).

    Time frame: From enrollment to the end of treatment at 8 weeks

  3. Reaction speed assessment

    Reaction speed is defined as the duration between the stimulus reaching the central nervous system and the execution of the appropriate motor response. It is closely associated with cognitive functions such as attention, processing speed, motor planning, and executive functions. Considering the age-related decline in processing speed and motor response, the Light Trainer Flash Light Exercise System (Reaction X) will be utilized to evaluate these parameters. Upper Limb Reaction Speed Assessment The assessment consists of two protocols, each lasting 30 seconds: Choice Reaction (Colored Light): To evaluate decision-making and reasoning, participants must respond to color-coded stimuli (e.g., blue light for the right hand and red light for the left). Lower Limb Reaction Speed Assessment This protocol evaluates decision-making and balance concurrently. Using their dominant leg, participants will deactivate specific colored sensors for 30 seconds.

    Time frame: From enrollment to the end of treatment at 8 weeks

  4. Performance-Oriented Mobility Assessment

    The Performance-Oriented Mobility Assessment (POMA), introduced to the literature by Tinetti in 1986, is frequently used to assess balance and gait in elderly individuals and to assess the risk of falls in individuals with conditions affecting balance and gait (Tinetti, 1986). POMA, whose Turkish validity and reliability were conducted by Ağırcan, will be used in our research for the comprehensive assessment of gait and balance (Ağırcan, 2009). Permissions from the authors are provided as an attachment.

    Time frame: From enrollment to the end of treatment at 8 weeks

  5. Berg Balance Assessment

    Berg Balance Test (BBS), one of the frequently used tests in balance assessment in elderly individuals, has a test-retest reliability with an ICC (Intraclass Correlation Coefficient) of 0.91 and high inter-rater reliability with an ICC of 0.97 (Neuls, 2011). BBS, which consists of 14 different tasks or activities, is scored from 0 to 4 for tasks such as sitting to standing, standing without support, sitting without support, etc. The total score varies between 0 and 56, with a high score being interpreted as better balance. The scale, which was validated in Turkish by Şahin and colleagues, shows a high risk of falling, a score of 0 to 20 indicates a moderate risk of falling, a score of 21 to 40 indicates a moderate risk of falling, and a score of 41 to 56 indicates a low risk of falling (Sahin, 2008).

    Time frame: From enrollment to the end of treatment at 8 weeks

  6. Physical Activity Enjoyment Scale

    The Physical Activity Enjoyment Scale is one of the scales used to measure enjoyment in physical activity. The test-retest reliability of the scale was reported to be 0.69, showing strong internal consistency and reliability (Weyland et al., 2024). The Turkish validity and reliability of the scale, which consists of 8 items and a single dimension, was conducted by Özkurt et al. in 2022, and it was reported that the Turkish form can be used as a valid and reliable measurement tool (Özkurt, 2022).

    Time frame: From enrollment to the end of treatment at 8 weeks

  7. Exercise Adherence and Participation Rate

    To monitor exercise adherence, session attendance will be recorded by the researchers using an Exercise Program Attendance Tracking Chart. Participants who fail to attend four or more sessions (representing a dropout/non-attendance rate of ≥25%) of the 16-session program will be excluded from the study. Furthermore, adherence rates will be compared across the exercise groups.

    Time frame: From enrollment to the end of treatment at 8 weeks

Other outcomes

  1. Satisfaction Level

    Participant satisfaction levels regarding the program will be evaluated using a researcher-developed questionnaire. Participants will be asked to rate their overall satisfaction with the intervention, their willingness to participate in the program again if it were repeated, and other satisfaction-related metrics on a 10-point scale (ranging from 1 to 10, where 10 represents the highest level of satisfaction).

    Time frame: From enrollment to the end of treatment at 8 weeks

07

Study locations

1 of 1 sites recruiting
  • Balıkesir Üniversitesi
    Balıkesir, Turkey (Türkiye)
    Recruiting
    • GULFİDAN TOKGÖZ, Lecturer, PhD (c) · Contactgulfidan.tokgoz@gmail.com · 0552 022 76 32
    • Bilal Katipoğlu, Assoc. Prof. Dr. · Sub investigator
    • Nilay ARMAN, Assoc. Prof. Dr. · Sub investigator
08

References and documents

Publications

  • Davranche K, Burle B, Audiffren M, Hasbroucq T. Physical exercise facilitates motor processes in simple reaction time performance: an electromyographic analysis. Neurosci Lett. 2006 Mar 20;396(1):54-6. doi: 10.1016/j.neulet.2005.11.008. Epub 2006 Jan 10. PubMed 16406344 ↗
  • Garcia MAC, Souza VH. The (un)standardized use of handheld dynamometers on the evaluation of muscle force output. Braz J Phys Ther. 2020 Jan-Feb;24(1):88-89. doi: 10.1016/j.bjpt.2019.10.004. Epub 2019 Nov 13. No abstract available. PubMed 31740163 ↗
  • Zirek E, Mustafaoglu R, Cicek A, Ahmed I, Mavromoustakos S. Reliability and Validity of the Turkish Version of the Modified Dynamic Gait Index in the Elderly. Eval Health Prof. 2023 Jun;46(2):135-139. doi: 10.1177/01632787221128311. Epub 2022 Sep 17. PubMed 36121068 ↗
  • Alghwiri AA. Reliability and validity of the Arabic Dynamic Gait Index in people poststroke. Top Stroke Rehabil. 2014 Mar-Apr;21(2):173-9. doi: 10.1310/tsr2102-173. PubMed 24710977 ↗
  • Pahor M, Guralnik JM, Ambrosius WT, Blair S, Bonds DE, Church TS, Espeland MA, Fielding RA, Gill TM, Groessl EJ, King AC, Kritchevsky SB, Manini TM, McDermott MM, Miller ME, Newman AB, Rejeski WJ, Sink KM, Williamson JD; LIFE study investigators. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA. 2014 Jun 18;311(23):2387-96. doi: 10.1001/jama.2014.5616. PubMed 24866862 ↗
  • Corsonello A, Lattanzio F, Pedone C, Garasto S, Laino I, Bustacchini S, Pranno L, Mazzei B, Passarino G, Incalzi RA; Pharmacosurveillance In The Elderly Care Pvc Study Investigators. Prognostic significance of the short physical performance battery in older patients discharged from acute care hospitals. Rejuvenation Res. 2012 Feb;15(1):41-8. doi: 10.1089/rej.2011.1215. Epub 2011 Oct 17. PubMed 22004280 ↗
  • Pavasini R, Guralnik J, Brown JC, di Bari M, Cesari M, Landi F, Vaes B, Legrand D, Verghese J, Wang C, Stenholm S, Ferrucci L, Lai JC, Bartes AA, Espaulella J, Ferrer M, Lim JY, Ensrud KE, Cawthon P, Turusheva A, Frolova E, Rolland Y, Lauwers V, Corsonello A, Kirk GD, Ferrari R, Volpato S, Campo G. Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis. BMC Med. 2016 Dec 22;14(1):215. doi: 10.1186/s12916-016-0763-7. PubMed 28003033 ↗
  • Li Y, Yu N, Zhang C, Song Q, Wang J, Sun W. Test-retest reliability of kinematic and kinetic parameters during dual-task stair walking in the elderly. Front Physiol. 2023 May 9;14:1177159. doi: 10.3389/fphys.2023.1177159. eCollection 2023. PubMed 37228826 ↗
  • Casana J, Calatayud J, Silvestre A, Sanchez-Frutos J, Andersen LL, Jakobsen MD, Ezzatvar Y, Alakhdar Y. Knee Extensor Muscle Strength Is More Important Than Postural Balance for Stair-Climbing Ability in Elderly Patients with Severe Knee Osteoarthritis. Int J Environ Res Public Health. 2021 Mar 31;18(7):3637. doi: 10.3390/ijerph18073637. PubMed 33807414 ↗
  • Soubra R, Mourad-Chehade F, Chkeir A. Automation of the Timed Up and Go Test Using a Doppler Radar System for Gait and Balance Analysis in Elderly People. J Healthc Eng. 2023 Jun 29;2023:2016262. doi: 10.1155/2023/2016262. eCollection 2023. PubMed 37426725 ↗
  • Reis M, Teixeira M, Carvao C, Martins AC. Validity and Reliability of the Self-Administered Timed Up and Go Test in Assessing Fall Risk in Community-Dwelling Older Adults. Geriatrics (Basel). 2025 Apr 29;10(3):62. doi: 10.3390/geriatrics10030062. PubMed 40407569 ↗

Individual participant data

Plan to share: No

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Dec 2025 (actual). Primary completion is estimated for Nov 2026, 11 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 8, 2026: primary completion Mar 2026 → Nov 2026 and completion Jun 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 20, 2025
First posted
Jul 1, 2025
StartActual
Dec 25, 2025
Primary completionEst.
Nov 30, 2026was Mar 2026
CompletionEst.
Dec 30, 2026was Jun 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Mar 25, 2026→Nov 30, 2026
Oct 8, 2026
Study completion
Jun 30, 2026→Dec 30, 2026
Oct 8, 2026
Primary outcomes
2 description edited
What changed in the outcomes
  • DescriptionCognitive Officer TUG-SCT: how it is measured was reworded
  • DescriptionStair Climbing Test (SCT): how it is measured was reworded
Nov 12, 2026
Show all 2 updates
  1. Nov 12, 2026
    Primary outcomes 2 description edited
    What changed in the outcomes
    • DescriptionCognitive Officer TUG-SCT: how it is measured was reworded
    • DescriptionStair Climbing Test (SCT): how it is measured was reworded
    + 3 other changes: verification date, oversight details and design details
  2. Oct 8, 2026
    Primary completion Mar 25, 2026→Nov 30, 2026
    Study completion Jun 30, 2026→Dec 30, 2026
    + 2 other changes: verification date and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07045259
Responsible party
Gulfidan Tokgoz (İstanbul Üniversitesi-Cerrahpasa, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Jul 1, 2025
Start date
Dec 25, 2025
Primary completion
Nov 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Nov 12, 2026

Study contacts

GULFİDAN TOKGÖZ, Lecturer, PhD (c)
Contact
gulfidan.tokgoz@gmail.com
+90552 022 76 32
Saime Nilay ARMAN, Assoc. Prof. Dr.
Contact
saimenilayarman@istanbul.edu.tr
+90553 455 87 07
Gulfidan TOKGÖZ, Lecturer, PhD (c)
principal investigator · İstanbul University-Cerrahpasa
Saime Nilay ARMAN, Assoc. Prof. Dr.
study director · İstanbul University-Cerrahpasa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion